Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.parmaxpharma.com | |
Market Cap | 12.72 Cr. | |
Enterprise Value(EV) | 18.25 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -6.90 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.44 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 6.51 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 5.22 | Calculated using Price: 34.00 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.37 Cr. | 3,741,300 Shares |
FaceValue | 10 | |
Company Profile | ||
Parmax Pharma was incorporated on November 02, 1994. The certificate of commencement of business was received by the company on March 10, 1995.The IPO of the company was January 30, 1996 with 5100800 shares of Rs10/-each. The promoters were earlier in manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The company then discontinued its business activities for few years due to various reasons. The company also plans to extend its activity in formulation of Tablets, Capsules, Ointments, & Injectable. |
1 Day |
|
-4.36% |
1 Week |
|
-3.13% |
1 Month |
|
-9.09% |
3 Month |
|
-6.46% |
6 Month |
|
+9.85% |
1 Year |
|
-35.85% |
2 Year |
|
+13.52% |
5 Year |
|
+100% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 1.16 | 0.70 | -0.12 | -0.28 | 0.02 | 3.71 | 18.19 | 22.55 | 3.38 | |
Return on Capital Employed (%) | 1.01 | 0.88 | 0.28 | 0.18 | 0.81 | 1.96 | 10.19 | 16.25 | 6.62 | |
Return on Assets (%) | 0.73 | 0.45 | -0.08 | -0.12 | 0.00 | 0.43 | 2.11 | 3.45 | 0.70 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 4 | |
Non Curr. Liab. | 1 | 1 | 0 | 1 | 2 | 5 | 5 | 6 | 5 | 6 | |
Curr. Liab. | 0 | 0 | 0 | 2 | 10 | 10 | 11 | 11 | 7 | 6 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 5 | 8 | 17 | 20 | 21 | 23 | 18 | 16 | |
Non Curr. Assets | 3 | 3 | 3 | 3 | 6 | 9 | 10 | 11 | 11 | 11 | |
Curr. Assets | 2 | 2 | 2 | 4 | 9 | 9 | 9 | 10 | 7 | 5 | |
Misc. Exp. not W/O | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | ||
Total Assets | 5 | 5 | 5 | 8 | 17 | 20 | 21 | 23 | 18 | 16 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 12 | 12 | 21 | 26 | 18 | 14 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 0 | 0 | 0 | 0 | 12 | 12 | 21 | 26 | 18 | 14 | |
Total Expenditure | 0 | 0 | 0 | 0 | -11 | -11 | -19 | -23 | -16 | -14 | |
PBIDT | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 3 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Depreciation | -1 | -1 | -1 | -2 | -2 | -2 | |||||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -3 | |||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | -7 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | 4 | 1 | 3 | 4 | 1 | ||
Cash Fr. Inv. | 0 | -4 | -3 | -2 | -3 | -2 | |||||
Cash Fr. Finan. | 0 | 0 | 0 | 1 | 1 | 3 | 0 | 0 | -1 | ||
Net Change | 0 | 0 | 0 | 1 | 1 | 0 | 1 | -2 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 1 |
Tue, 17 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022. |
Fri, 30 Dec 2022
Closure of Trading Window Subject: Closure of trading window |
Sat, 24 Dec 2022
Clarification On Price Movement. Clarification on Price Movement. |
Thu, 02 Feb 2023 |
|
|
|
|
|